Abstract
Much of the recent research in asthma has focused on delineating the causative factors that contribute to the pathobiology of both airway eosinophilia and neutrophilia, and steroid-refractory disease. The distal airway, once thought to be a sterile environment, is now known to be a complex arena of microorganisms, termed the lung microbiome. Complementary and counterbalancing mechanisms are essential to maintaining homeostasis in this environment. An altered lung microbiome has been well described in asthma, with a higher burden of bacteria and differing species seen in asthmatic lungs compared with normal lungs, and these differences are more marked in severe asthma.
| Original language | English |
|---|---|
| Article number | DOI: 10.1016/j.chest.2015.12.038 |
| Pages (from-to) | 1121-1122 |
| Number of pages | 2 |
| Journal | Chest |
| Volume | 149 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Surfactant Protein-D and Asthma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver